Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium
批准号:
9117092
负责人:
Steven A Belinsky
金额:
$54.5万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2020-03-31
关键词:
AcidsAcuteAerosolsAffectAgarAlcoholsAlkanesBiologicalBiological AssayBiological ModelsBreathingBurn injuryCatalogingCatalogsCell LineCellsChemicalsChronicCigaretteComet AssayComplexComplex MixturesDNA AdductsDNA DamageDeoxyguanosineDepositionDevelopmentDevicesDiacetylDoseElectronic cigaretteEpigenetic ProcessEpithelial CellsEvolutionExposure toFlavoringFoodFormaldehydeGasesGene ChipsGene ExpressionGenerationsGenesGlycerolGrowthHeatingHomeostasisHumanIn VitroIndustryLinkLong-Term EffectsLung diseasesMalignant NeoplasmsMalignant neoplasm of lungMeasuresMetalsMethodsMethylationMicroRNAsMinorModelingMolecularMutationNatureNicotineNude MiceOralOral cavityParticle SizePhysiologicalPoisonPoliciesPopulationPremalignantPropertyPropylene GlycolsProtocols documentationReactive Oxygen SpeciesRelative RisksResearchRespiratory SystemRespiratory tract structureRiskRisk AssessmentSafetyStatistical ModelsStem cellsSystemTechniquesTestingThe Cancer Genome AtlasTobaccoTobacco-Associated CarcinogenToxic effectToxicant exposureToxicologyTracheaTreesXenograft procedurecancer riskcell motilitycytotoxiccytotoxicitygene inductiongenotoxicityin vitro Modelinsightmalignant mouth neoplasmmeetingsmicronucleusoral cavity epitheliumparticlepredictive toolspublic health relevanceresponsetobacco carcinogenesistooltumorigenicvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our understanding of the molecular mechanisms and their relationship to the development of cancer has enabled the creation of a set of predictive tools that can be applied across a range of existing and new tobacco products to inform risk for cancer. These tools are accurate in short-term assays, applicable to human progenitor cells for cancer, and recapitulate changes seen in primary cancer that can take decades to develop. Quantitative results from such assays should be highly useful for establishing regulatory policies and communicating relative risk. We have developed an in vitro pre-malignancy model using metabolically competent immortalized human bronchial epithelial cells that will now be extended to three oral epithelial cell lines to test the acute and chronic effects of exposure to electronic
cigarette (E-cig) aerosols containing nicotine and common classes of flavor chemicals. The E-cig industry is in a major period of evolution with the release of more than one hundred delivery devices that afford the user the opportunity to adjust the voltage for aerosol generation and to customize their nicotine solution with a menu of >7764 unique "flavor chemicals". Most of these flavor chemicals are confectionary in nature, food grade, and generally recognized as safe when used as food constituents. However, the toxicological effects of flavors when inhaled after heating or burning and how they may influence the deposition profile of the components released from nicotine (e.g., NNK, formaldehyde) are unknown. For example, diacetyl and acetyl propionyl are associated with respiratory disease when inhaled, found in 74% of 159 tested flavorings, and readily detected in the generated aerosols at levels that exceed consumer safety. The 12 major classes of flavor chemicals with and without the addition of a standard nicotine solution generated at a low and high voltage will be studied to provide a comprehensive assessment of the toxicological effects of the aerosols generated from these complex mixtures on the oral epithelial cell. The aerosols generated from the different nicotine-flavor chemical mixtures with respect to toxicological components, the effect of increased voltage on aerosol composition, and how these variables impact the deposition profile within the oral-tracheal tract will be characterized. A sensitive readout will be obtained by acute and chronic in vitro exposure of these oral epithelial cell lines to the different E-cig aerosols to inform many aspects related o the cytotoxic, genotoxic, and carcinogenic potential of these E-cig products. The compilation of these findings will support development of a risk model that links chemical constituents within the E-cig aerosol to the detrimental biological effects observed in the in vitro studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
-
批准号:10760630
-
项目类别:
-
资助金额:$86.11万
-
财政年份:2023
-
负责人:Steven A Belinsky
-
依托单位:
Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats
-
批准号:10413991
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2020
-
负责人:Steven A Belinsky
-
依托单位:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
-
批准号:10470762
-
项目类别:
-
资助金额:$80.61万
-
财政年份:2018
-
负责人:Steven A Belinsky
-
依托单位:
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
-
批准号:9788459
-
项目类别:
-
资助金额:$64.64万
-
财政年份:2018
-
负责人:Steven A Belinsky
-
依托单位:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
-
批准号:10296957
-
项目类别:
-
资助金额:$77.6万
-
财政年份:2018
-
负责人:Steven A Belinsky
-
依托单位:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
-
批准号:9768991
-
项目类别:
-
资助金额:$81.21万
-
财政年份:2018
-
负责人:Steven A Belinsky
-
依托单位:
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
-
批准号:9976518
-
项目类别:
-
资助金额:$63.86万
-
财政年份:2018
-
负责人:Steven A Belinsky
-
依托单位:
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
-
批准号:10208793
-
项目类别:
-
资助金额:$47.58万
-
财政年份:2016
-
负责人:Steven A Belinsky
-
依托单位:
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
-
批准号:10296534
-
项目类别:
-
资助金额:$28.83万
-
财政年份:2016
-
负责人:Steven A Belinsky
-
依托单位:
Histone Methyltransferases as a Target for Lung Cancer Prevention
-
批准号:8856526
-
项目类别:
-
资助金额:$58.15万
-
财政年份:2014
-
负责人:Steven A Belinsky
-
依托单位:
Histone Methyltransferases as a Target for Lung Cancer Prevention
-
批准号:8712907
-
项目类别:
-
资助金额:$57.62万
-
财政年份:2014
-
负责人:Steven A Belinsky
-
依托单位:
Histone Methyltransferases as a Target for Lung Cancer Prevention
-
批准号:9295840
-
项目类别:
-
资助金额:$77.87万
-
财政年份:2014
-
负责人:Steven A Belinsky
-
依托单位:
Histone Methyltransferases as a Target for Lung Cancer Prevention
-
批准号:9093756
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2014
-
负责人:Steven A Belinsky
-
依托单位:
Epigenetic Changes Link COPD and Lung Cancer
-
批准号:8097889
-
项目类别:
-
资助金额:$84.95万
-
财政年份:2011
-
负责人:Steven A Belinsky
-
依托单位:
Epigenetic Changes Link COPD and Lung Cancer
-
批准号:8312474
-
项目类别:
-
资助金额:$80.74万
-
财政年份:2011
-
负责人:Steven A Belinsky
-
依托单位:
Epigenetic Changes Link COPD and Lung Cancer
-
批准号:8474726
-
项目类别:
-
资助金额:$74.91万
-
财政年份:2011
-
负责人:Steven A Belinsky
-
依托单位:
Epigenetic Changes Link COPD and Lung Cancer
-
批准号:8677815
-
项目类别:
-
资助金额:$75.09万
-
财政年份:2011
-
负责人:Steven A Belinsky
-
依托单位:
Biomarkers to Assess Selenium Chemoprevention for NSCLC
-
批准号:7808538
-
项目类别:
-
资助金额:$121.26万
-
财政年份:2009
-
负责人:Steven A Belinsky
-
依托单位:
Factors for Epigenetic Silencing of Lung Cancer Genes
-
批准号:7909587
-
项目类别:
-
资助金额:$22.16万
-
财政年份:2009
-
负责人:Steven A Belinsky
-
依托单位:
P2: Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection
-
批准号:7567919
-
项目类别:
-
资助金额:$79.38万
-
财政年份:2008
-
负责人:Steven A Belinsky
-
依托单位:
海外基金